Welcome : Guest

Cipher Pharmaceuticals, Inc. (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Cipher Pharmaceuticals, Inc., which is principally involved in Pharmaceuticals Business. Illustrated with 24 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-32460
Price: $1200
Company Type: Public
Pages: 26
Date: November 2016
Market Data Tables: 24

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
  CIPHER PHARMACEUTICALS, INC. (CANADA) (Complete Report)Pages : 26|$ 1200.00
1. COMPANY SNIPPETS......1
2. MAJOR PRODUCTS AND SERVICES......2
3. SALES DATA......3
Table 1: Cipher Pharmaceuticals, Inc.'s Sales by Geographic Region Worldwide (2015) in Percentage for Canada, and United States......3
4. MARKET OVERVIEW......4
Acne Drugs......4
Table 2: Acne Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Isotretinoin, Topicals (Retinoid/Antibiotics), Oral Antibiotics, and Others......4
Table 3: Anti-acne Topical Dermatology Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Acne, AK + Psoriasis + Dermatitis + Others, Anti-Fungal Combo, Anti-Infective, Coagulants, Corticosteroids Combo, and Corticosteroids Plain......5
Table 4: Acne Drugs Market by Segments in the US (2015) - Percentage Share Breakdown by Volume for Orals and Topicals......6
Dermatological Drugs......7
Table 5: Dermatological Drug Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......7
Table 6: Dermatology Drugs Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......8
Table 7: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......9
Table 8: Dermal Substitutes Chronic Wound Market by Category in the US (2015) - Percentage Share Breakdown by Value for Diabetic Foot Ulcer, Pressure Ulcer and Venous Leg Ulcer......10
Table 9: Prevalence & Severity of Actinic Keratoses Market by Category in the US (2015) - Percentage Share Breakdown by Value for Minimal, Moderate, Severe, and Others......11
Ulcer Drugs......12
Table 10: Ulcer Drugs by Category in the US (2015) - Percentage Share Breakdown by Number of Prescriptions for H2 Blockers, Proton Pump Inhibitors, and Others......12
Topical Prescription Acne Drugs......13
Table 11: Topical Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Managed Medicaid Payment, Medicare Payment......13
Table 12: Market Shares of Leading Topical Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Acanya, Aczone, Differin, Epiduo, Finacea, and Others......14
Oral Prescription Acne Drugs......15
Table 13: Oral Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Medicare Payment......15
Table 14: Market Shares of Leading Oral Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Doryx, Monodox, Oracea, Solodyn, and Others......16
Acute Bacterial Skin and Skin Structure Infection Antibiotics (Branded)......17
Table 15: Branded Acute Bacterial Skin and Skin Structure Infection Antibiotic Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Cubicin (Daptomycin), Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......17
Dermatology Biologics......18
Table 16: Dermatology Biologics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......18
5. COMPETITIVE LANDSCAPE......19
Acne Drugs......19
Table 17: Market Shares of Leading Branded Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, Inc., Galderma, Valeant Pharmaceuticals International, Inc. and Others......19
Table 18: Market Shares of Leading Branded Anti-acne Treatement Providers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, plc, Bayer AG, Galderma S.A., GlaxoSmithKline Pharmaceuticals Ltd., Prasco Laboratories, Valeant Pharmaceuticals International, Inc., and Others......20
Table 19: Market Shares of Leading Generic Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan, Perrigo Company, Pfizer, Inc., Sandoz and Others......21
Table 20: Market Shares of Leading Generic Anti-acne Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan N.V., Perrigo Company plc, Pfizer, Inc., Prasco Laboratories, Rouses Point Pharmaceuticals LLC, Sandoz Inc., Taro Pharmaceutical Industries Ltd., and Private Label......22
Dermatological Products......23
Table 21: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......23
Table 22: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......24
Table 23: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......25
Table 24: Market Shares of Leading Drugs for Treatment of Skin Infection in the US (2015) - Percentage Share Breakdown by Value for CUBICIN, VANCOMYCIN, ZYVOX IV and Others......26